Charles River Leverages Virtual Control Groups in GLP Studies

What happened

Charles River Laboratories said its Virtual Control Group database and method will be used in an upcoming Good Laboratory Practice-compliant study for Ipsen, reducing animal use in safety research.

Confirmed

Global impact / market context

If drug developers accept digital control groups, Charles River could sell more advisory and data services per safety study while cutting animal costs, which means its profit per sale may rise as clients save money and time.

Analyst inference

Investors in contract research firms are watching whether regulators accept alternatives to animal testing, because wider adoption could shift study budgets toward data services and away from animal facilities, changing revenue mix across the industry.

Analyst inference

What to watch

1. Charles River said its Virtual Control Group program operates under the Alternative Methods Advancement Project, which it describes as an effort to minimize animal use in research whenever scientifically appropriate. Confirmed
2. The upcoming study for Ipsen will test whether the company's virtual control approach, combining historical data, statistical methods and AI analytics, meets Good Laboratory Practice standards in a regulated safety study. Proposed
3. Watch whether Ipsen or other drug developers sign further virtual control studies, since repeat use would show the method is accepted and could move study spending toward Charles River's data services. Analyst inference

Evidence

• Original source link unavailable